RBOT Vicarious Surgical Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1812173 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY20.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-177.5%
ROA-115.0%
ROIC (approx.)-178.7%
Asset turnover—
Leverage & solvency
Liabilities / assets49.7%
Debt / equity0.00x
Current ratio2.97x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.90x
Accruals ratio-11.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $33.60M | $40.16M |
| SG&A expense | $15.20M | $21.88M |
| Operating income | -$50.03M | -$66.56M |
| Pretax income | -$50.18M | -$63.22M |
| Net income | -$50.18M | -$63.22M |
| EBITDA | -$48.60M | -$64.45M |
| EPS (diluted) | — | — |
| Weighted avg. shares (diluted) | 6.13M | 5.89M |
| Balance sheet | ||
| Cash & equivalents | $2.57M | $9.74M |
| Short-term investments | $7.22M | $39.36M |
| Current assets | $11.58M | $51.70M |
| PP&E, net | $1.27M | $4.48M |
| Total assets | $19.58M | $67.72M |
| Current liabilities | $3.90M | $7.67M |
| Total liabilities | $9.74M | $21.02M |
| Shareholders' equity | $9.84M | $46.70M |
| Cash flow statement | ||
| Operating cash flow | -$45.08M | -$49.96M |
| Capital expenditure | $132,000 | $180,000 |
| Free cash flow | -$45.21M | -$50.14M |
| Investing cash flow | $32.15M | $6.86M |
| Financing cash flow | $5.76M | $8,000 |
| Depreciation & amortization | $1.43M | $2.11M |
| Stock-based compensation | $8.13M | $11.90M |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.